Recall of pholcodine - Pholcodine Statement

This statement has been prepared in response to the decision of the Australian Government Therapeutic Goods Administration (TGA) to withdraw pholcodine-containing products from the market. Evidence shows that pholcodine consumption in the 12-month period prior to a general an...

PS40(G)BP Position statement on the relationship between fellows, trainees and the healthcare industry Background Paper

ANZCA social media policy

Into the deep with a breakthrough consciousness study | COVID-19: How we’re working and living with the virus two years on | Beyond city limits: Twin cities provide regional opportunities for trainees